Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 2
2009 3
2010 3
2011 2
2012 3
2013 1
2014 1
2019 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox).
Vanholder R, Argilés A, Jankowski J; European Uraemic Toxin Work Group (EUTox). Vanholder R, et al. Clin Kidney J. 2021 Jan 24;14(6):1514-1523. doi: 10.1093/ckj/sfab011. eCollection 2021 Jun. Clin Kidney J. 2021. PMID: 34413975 Free PMC article.
This picture is to a significant extent defined by retention of metabolites and peptides that with a preserved kidney function are excreted or degraded by the kidneys. In as far as those solutes have a negative biological/biochemical impact, they are called uraemic …
This picture is to a significant extent defined by retention of metabolites and peptides that with a preserved kidney function are excreted …
Review on uremic toxins: classification, concentration, and interindividual variability.
Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic Toxin Work Group (EUTox). Vanholder R, et al. Kidney Int. 2003 May;63(5):1934-43. doi: 10.1046/j.1523-1755.2003.00924.x. Kidney Int. 2003. PMID: 12675874 Free article. Review.
BACKGROUND: The choice of the correct concentration of potential uremic toxins for in vitro, ex vivo, and in vivo experiments remains a major area of concern; errors at this level might result in incorrect decisions regarding therpeutic correction of uremia and rela …
BACKGROUND: The choice of the correct concentration of potential uremic toxins for in vitro, ex vivo, and in vivo experiments …
Effects of an SGLT Inhibitor on the Production, Toxicity, and Elimination of Gut-Derived Uremic Toxins: A Call for Additional Evidence.
Evenepoel P, Meijers B, Masereeuw R, Lowenstein J. Evenepoel P, et al. Toxins (Basel). 2022 Mar 15;14(3):210. doi: 10.3390/toxins14030210. Toxins (Basel). 2022. PMID: 35324707 Free PMC article. Review.
This suppresses protein fermentation, and thus the generation of uremic toxins such as phenols and indoles. It is acknowledged that such a shift in gut microbial metabolism yields health benefits for the host. SGLT inhibition, in addition, may be hypothesized to fos …
This suppresses protein fermentation, and thus the generation of uremic toxins such as phenols and indoles. It is acknowledged …
A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients.
Sternkopf M, Thoröe-Boveleth S, Beck T, Oleschko K, Erlenkötter A, Tschulena U, Steppan S, Speer T, Goettsch C, Jankowski V, Jankowski J, Noels H; European Uremic Toxin Work Group-EUTox. Sternkopf M, et al. Toxins (Basel). 2019 Jul 3;11(7):389. doi: 10.3390/toxins11070389. Toxins (Basel). 2019. PMID: 31277311 Free PMC article.
Hydrophobic uremic toxins accumulate in patients with chronic kidney disease, contributing to a highly increased cardiovascular risk. ...The adsorption capacity was quantified using analytical chromatography after perfusion of the particles with an albumin solution …
Hydrophobic uremic toxins accumulate in patients with chronic kidney disease, contributing to a highly increased cardiovascula …
Review on uraemic solutes II--variability in reported concentrations: causes and consequences.
Vanholder R, Meert N, Schepers E, Glorieux G, Argiles A, Brunet P, Cohen G, Drüeke T, Mischak H, Spasovski G, Massy Z, Jankowski J; European Uremic Toxin Work Group (EUTox). Vanholder R, et al. Nephrol Dial Transplant. 2007 Nov;22(11):3115-21. doi: 10.1093/ndt/gfm151. Epub 2007 Jun 5. Nephrol Dial Transplant. 2007. PMID: 17550927 Review.
The aim of this manuscript is to initiate a constructive discussion about deviations in measured concentrations of uraemic solutes; these deviations, if not perceived or handled appropriately, may lead to incorrect interpretations of the pathophysiological role of uraem …
The aim of this manuscript is to initiate a constructive discussion about deviations in measured concentrations of uraemic solutes; t …
Modulation of NADPH oxidase activity by known uraemic retention solutes.
Schulz AM, Terne C, Jankowski V, Cohen G, Schaefer M, Boehringer F, Tepel M, Kunkel D, Zidek W, Jankowski J; European Uremic Toxin Work Group (EUTox). Schulz AM, et al. Eur J Clin Invest. 2014 Aug;44(8):802-11. doi: 10.1111/eci.12297. Eur J Clin Invest. 2014. PMID: 25041433
Furthermore, the leucocytes were lysed and incubated in the presence of uraemic retention solute of interest and diphenyleneiodonium chloride (DPI), an inhibitor of NADPH oxidase. ...Oxalate has been characterized as the strongest inhibitor of NADPH oxidase (90% of DPI inh …
Furthermore, the leucocytes were lysed and incubated in the presence of uraemic retention solute of interest and diphenyleneiodonium …
Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia.
Cohen G, Glorieux G, Thornalley P, Schepers E, Meert N, Jankowski J, Jankowski V, Argiles A, Anderstam B, Brunet P, Cerini C, Dou L, Deppisch R, Marescau B, Massy Z, Perna A, Raupachova J, Rodriguez M, Stegmayr B, Vanholder R, Hörl WH; European Uremic Toxin Work Group (EUTox). Cohen G, et al. Nephrol Dial Transplant. 2007 Dec;22(12):3381-90. doi: 10.1093/ndt/gfm210. Epub 2007 Aug 27. Nephrol Dial Transplant. 2007. PMID: 17724037 Review. No abstract available.
The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients.
de Oliveira RB, Liabeuf S, Okazaki H, Lenglet A, Desjardins L, Lemke HD, Vanholder R, Choukroun G, Massy ZA; European Uremic Toxin Work Group (EUTox). de Oliveira RB, et al. Clin Kidney J. 2013 Feb;6(1):63-70. doi: 10.1093/ckj/sfs176. Epub 2012 Jan 1. Clin Kidney J. 2013. PMID: 27818752 Free PMC article.
The results of animal and clinical studies have revealed a positive relationship between leptin and vascular smooth muscle cell counts and calcification, arterial rigidity, carotid thickness and the incidence of CVD. However, despite leptin fulfilling the definition of a uremi …
The results of animal and clinical studies have revealed a positive relationship between leptin and vascular smooth muscle cell counts and c …
Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients.
Fourdinier O, Schepers E, Metzinger-Le Meuth V, Glorieux G, Liabeuf S, Verbeke F, Vanholder R, Brigant B, Pletinck A, Diouf M, Burtey S, Choukroun G, Massy ZA, Metzinger L; European Uremic Toxin Work Group-EUTox. Fourdinier O, et al. Sci Rep. 2019 Mar 14;9(1):4477. doi: 10.1038/s41598-019-41101-8. Sci Rep. 2019. PMID: 30872798 Free PMC article.
Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease.
Schepers E, Barreto DV, Liabeuf S, Glorieux G, Eloot S, Barreto FC, Massy Z, Vanholder R; European Uremic Toxin Work Group (EUTox). Schepers E, et al. Clin J Am Soc Nephrol. 2011 Oct;6(10):2374-83. doi: 10.2215/CJN.01720211. Epub 2011 Aug 4. Clin J Am Soc Nephrol. 2011. PMID: 21817129 Free PMC article.
17 results